Xu Jianguo

chinacdc.cn | Updated: 2022-01-05
Position: Director of State Key Laboratory of Infectious Disease Prevention and Control, Chinese Center for Disease Control and Prevention (China CDC); Academician of Chinese Academy of Engineering
Xu Jianguo is the director of State Key Laboratory of Infectious Disease Prevention and Control of the Chinese Center for Disease Control and Prevention (China CDC), and the deputy chief technical officer of the National Science and Technology Major Project on Prevention and Control of Major Infectious Diseases such as AIDS and Viral Hepatitis. His projects were financed by the National Science Fund for Distinguished Young Scholars in 1996 and he won the Second Prize of the National Science and Technology Progress Award in 1997, as well as the Medical Pharmacy Award of the Ho Leung Ho Lee Prize for Science and Progress in 2001. He was elected an academician of the Chinese Academy of Engineering in 2011.
Xu and his team have been on the front line for a long time, engaged in the pathogenetic research of new, sudden and unexplained infectious disease outbreaks. They have presided over the completion of the pathogenetic investigation of several infectious disease outbreaks and events with great impact in China, including:
1. a multibacterial synergistic gangrene in a child in Shandong province in 1995;
2. a stellate Nocardia infection in a hospital in Sichuan province in 1997; 
3. an E. coli O157:H7 outbreak in Suwan in 1999; 
4. an outbreak of human infection with sequence 7 Streptococcus suis in Sichuan province in 2005; 
5. discovery and naming of Neisseria meningitidis sequence group 4821 in 2005; 
6. discovery of human granulocyte anaerobes human-to-human transmission in China in 2006; 
7. imported anthrax during the Olympic Games in 2008; 
8. discovery and naming of Shigella fowleri serotype Xv in 2010; 
9. initiation of construction of PulseNet China;
10. dealing with COVID-19 Pandemic.
Xu's achievements have improved the country’s scientific and technological level and control of the emergency response to infectious disease epidemics. Apart from his contributions to the control of pandemics, he has also published several influential papers in prestigious international journals including JAMA, The Lancet, and Clinical Infectious Disease.